Literature DB >> 4804289

Increased cytolytic effect of immune lymphocytes in a syngeneic tumour system following simple purification procedures.

D M Vasudevan, K T Brunner, J C Cerottini.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4804289      PMCID: PMC2149067     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


× No keyword cloud information.
  7 in total

1.  The separation of sub-populations of T and B lymphocytes.

Authors:  K Shortman; J C Cerottini; K T Brunner
Journal:  Eur J Immunol       Date:  1972-08       Impact factor: 5.532

2.  The separation of different cell classes from lymphoid organs. V. Simple procedures for the removal of cell debris. Damaged cells and erythroid cells from lymphoid cell suspensions.

Authors:  K Shortman; N Williams; P Adams
Journal:  J Immunol Methods       Date:  1972-05       Impact factor: 2.303

3.  Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.

Authors:  K T Brunner; J Mauel; J C Cerottini; B Chapuis
Journal:  Immunology       Date:  1968-02       Impact factor: 7.397

4.  The relative distribution of cytotoxic lymphocytes and of alloantibody-forming cells in albumin density gradients.

Authors:  J Pelet; K T Brunner; A A Nordin; J C Cerottini
Journal:  Eur J Immunol       Date:  1971-08       Impact factor: 5.532

5.  Enhanced immunogenicity of chemically-coated syngeneic tumor cells.

Authors:  W J Martin; J R Wunderlich; F Fletcher; J K Inman
Journal:  Proc Natl Acad Sci U S A       Date:  1971-02       Impact factor: 11.205

6.  In vitro activation of cellular immune response to Gross virus-induced lymphoma.

Authors:  M Ortiz de Landazuri; R B Herberman
Journal:  J Exp Med       Date:  1972-11-01       Impact factor: 14.307

7.  Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen.

Authors:  G A Currie; C Basham
Journal:  Br J Cancer       Date:  1972-12       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.